Yale Podnos - 20 Nov 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Medical Officer
Signature
By: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Yale Podnos
Issuer symbol
TOI
Transactions as of
20 Nov 2024
Net transactions value
-$408
Form type
4
Filing time
21 Nov 2024, 18:20:24 UTC
Previous filing
18 Nov 2024
Next filing
20 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Disposed to Issuer $232 -1,709 -2.2% $0.1360 74,261 20 Nov 2024 Direct F1, F2
transaction TOI Common stock Disposed to Issuer $36.04 -267 -0.36% $0.1350 73,994 20 Nov 2024 Direct F1, F2
transaction TOI Common stock Disposed to Issuer $140 -1,026 -1.4% $0.1360 72,968 20 Nov 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.135 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.